Cite
HARVARD Citation
von Wyl, V. et al. (2021). Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate. Multiple sclerosis. pp. 439-448. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
von Wyl, V. et al. (2021). Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate. Multiple sclerosis. pp. 439-448. [Online].